Related Experiment Video
Updated: Jan 28, 2026

Combining Behavior and EEG to Study the Effects of Mindfulness Meditation on Episodic Memory
Published on: May 11, 2020
In Vitro Effectiveness of Meropenem and Cefmetazole Combination Treatment Against KPC-2-Producing Enterobacteriaceae
Hideharu Hagiya1, Kotaro Aoki2, Yukihiro Akeda1
11 Department of Infection Control and Prevention, Graduate School of Medicine, Osaka University, Osaka, Japan.
Abstract:
Optimal treatment regimens are yet to be established for carbapenemase-producing Enterobacteriaceae (CPE). We assessed the in vitro efficacy of meropenem (MEM) and cefmetazole (CMZ) combination treatment against blaKPC-2-positive Enterobacteriaceae, in comparison with that of double-carbapenem therapy using ertapenem (ERT). We performed checkerboard assay for 10 blaKPC-2-positive clinical isolates and Klebsiella pneumoniae BAA-1705 (possessing blaKPC-2), with synergistic effect being defined by a fractional inhibitory concentration index of ≤0.5. Subsequently, we conducted time-kill assays using K. pneumoniae BAA-1705 with an initial inoculum of 104-107 colony forming unit (CFU)/mL. Bactericidal effect was defined as the reduction of initial bacterial count by ≥103 CFU/mL in 24 hr. Finally, we applied scanning electron microscopy to observe morphological changes induced by the combination of MEM and CMZ. Checkerboard assays revealed a synergistic effect in 7 out of 11 blaKPC-2 -positive Enterobacteriaceae when the MEM and CMZ combination was used, and no effect when the MEM and ERT combination was used. The minimum inhibitory concentration of MEM decreased 4-8-fold when combined with CMZ. Time-kill assays with an initial inoculum of 5 × 105 CFU/mL revealed regrowth under the combination of MEM and ERT (0.25 × minimum inhibitory concentration [MIC] each), whereas the combination of 0.25 × MIC each of MEM and CMZ exhibited bactericidal effect. Scanning electron microscopy results demonstrated that the combination of 0.5 × MIC MEM and 0.5 × MIC CMZ facilitated bacterial cell lysis compared with each antibiotic alone. The combination therapy using MEM and CMZ potentially has bactericidal effect against KPC-producing Enterobacteriaceae.
Insights
The combination of meropenem and cefmetazole shows potential bactericidal effects against KPC-producing Enterobacteriaceae. This novel combination therapy warrants further investigation for treating infections caused by these challenging bacteria.
Area of Science:
- Antimicrobial resistance
- Infectious diseases
- Pharmacology
Background:
- Carbapenemase-producing Enterobacteriaceae (CPE) pose a significant threat due to limited effective treatment options.
- Optimal therapeutic strategies for CPE infections remain to be established.
- Meropenem (MEM) and cefmetazole (CMZ) combination therapy is explored as a potential alternative.
Purpose of the Study:
- To evaluate the in vitro efficacy of meropenem (MEM) and cefmetazole (CMZ) combination against blaKPC-2-positive Enterobacteriaceae.
- To compare the efficacy of MEM-CMZ combination with double-carbapenem therapy using ertapenem (ERT).
- To assess the synergistic, bactericidal, and morphological effects of MEM-CMZ combination.
Main Methods:
- Checkerboard assays were performed on 11 blaKPC-2-positive Enterobacteriaceae isolates to determine synergistic effects (fractional inhibitory concentration index ≤0.5).
- Time-kill assays using Klebsiella pneumoniae BAA-1705 evaluated bactericidal activity (≥10^3 CFU/mL reduction in 24 hr).
- Scanning electron microscopy (SEM) was utilized to observe bacterial morphological changes induced by the drug combination.
Main Results:
- Synergistic effects were observed in 7 out of 11 isolates with the MEM-CMZ combination, whereas no synergy was found with MEM-ERT.
- MEM-CMZ combination demonstrated a 4-8 fold decrease in MEM's minimum inhibitory concentration (MIC).
- MEM-CMZ exhibited bactericidal effect at 0.25x MIC each, while MEM-ERT showed regrowth; SEM revealed bacterial cell lysis with MEM-CMZ.
Conclusions:
- The combination of meropenem and cefmetazole demonstrates significant in vitro synergistic and bactericidal activity against KPC-producing Enterobacteriaceae.
- MEM-CMZ combination therapy shows promise as a potential treatment against infections caused by blaKPC-2-positive Enterobacteriaceae.
- Further clinical investigations are warranted to validate the efficacy of this combination regimen.
More Related Videos
13:34A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds
Published on: April 6, 2016
05:18Author Spotlight: Ultrasound-Guided Needle Release Combined with Corticosteroid Injection for the Treatment of Supinator Syndrome
Published on: May 26, 2023
Related Concept Videos
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Combined Effects of Drugs: Antagonism
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
Biological Effects of Radiation
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
meta-Directing Deactivators: –NO2, –CN, –CHO, –⁠CO2R, –COR, –CO2H